Nam Ha Pharmaceutical Joint Stock Company proudly received the Outstanding Asian Enterprise Award at the APEA 2024 ceremony on October 3.

Mr. Ha Thanh Thuy, General Director of Nam Ha Pharmaceuticals, expressed his pride and gratitude, saying, “This award is not just a recognition of our efforts; it’s also a driving force for us to keep growing and innovating. It reflects our unwavering commitment to delivering high-quality products that people can trust.”

Over the years, Nam Ha Pharmaceuticals has earned numerous prestigious awards, including the Second-Class Labor Medal, Vietnam National Brand, Strong Vietnamese Brand Award, High-Quality Vietnamese Goods Certificate, and the Vietnamese Medicine Star Award.

Since its founding in 1960, Nam Ha has been on a mission to provide high-quality pharmaceutical products that improve lives. With over six decades of dedication, the company has introduced a range of trusted remedies like Bo Phe Nam Ha, Coldi-B DNH, Naphar Multi-Plus Effervescent Tablets, Mountain Fruit Deworming Tablets, and Naphacogyl. Among these, Nam Ha Lung Tonic and Coldi-B DNH have proudly carried the Vietnam National Brand title since 2020.

Nam Ha’s success lies in its commitment to quality and safety. Every product is rigorously tested to ensure it meets the highest standards. The company constantly improves its processes, ensuring that what reaches consumers is nothing short of the best.

To support this commitment, Nam Ha has invested heavily in upgrading its production systems to meet international standards, including WHO-GMP, GSP, GLP, and ISO-9001:2015. The company is also embracing cutting-edge technology and exploring new formulas to create even more effective medications that patients can trust.

Beyond business operations, Nam Ha actively engages in social initiatives, including healthcare support for underprivileged areas and charitable programs, reflecting its commitment to sustainable development.

On the global stage, Nam Ha is expanding its reach, with products now available in countries like Myanmar, Russia, Laos, Cambodia, Bangladesh, and parts of Africa. Looking ahead, the company is committed to further growing its international presence, enhancing product quality, and staying at the forefront of innovation. By investing in advanced technology and workforce development, Nam Ha aims to continue its journey as a leader in the pharmaceutical industry—bringing health, trust, and care to families everywhere.